Stocks to Watch Today: Tata Steel, Data Patterns, Voltas, Aster DM, GE Shipping, Gland Pharma, Finolex Cables, Cohance Lifesciences, Annu Projects, Lenskart in Focus on Muhurat Trading

Several stocks are likely to remain active during Muhurat Trading following quarterly earnings, regulatory updates, business agreements and large block deals. Here are the key developments investors should track.

Quarterly Earnings

• Tata Steel: Consolidated net profit increased 16.2% year-on-year to Rs 3,699.6 crore, while revenue rose 11.5% to Rs 65,436.2 crore.
• Data Patterns India: Consolidated profit declined 55.6% to Rs 21.8 crore from Rs 49.2 crore. Revenue stood at Rs 133.3 crore, compared with Rs 307.5 crore in the corresponding period.
• Voltas: Net profit climbed 53.5% to Rs 52.6 crore. Revenue grew 15.3% to Rs 2,706.6 crore.
• Aster DM Quality Care: Profit surged 138.2% to Rs 262 crore, while revenue jumped 136.3% to Rs 2,829.2 crore.
• Great Eastern Shipping Company: Consolidated profit advanced 118.3% to Rs 1,269.2 crore. Revenue increased 46.9% to Rs 1,824.4 crore.
• Gland Pharma: Profit rose 58.3% to Rs 290.7 crore, while revenue grew 23.3% to Rs 1,833.6 crore.
• Blue Dart Express: Consolidated profit increased 27.7% to Rs 103.9 crore. Revenue was up 14.5% at Rs 1,773.9 crore.
• Siemens: Profit grew 3.9% to Rs 504.2 crore, while revenue climbed 17% to Rs 5,734 crore.
• Finolex Cables: Profit surged 67.8% to Rs 272.9 crore. Revenue jumped 64.9% to Rs 2,269.3 crore.
• Cohance Lifesciences: Profit dropped 79.5% to Rs 15.2 crore, while revenue declined 14.2% to Rs 476.7 crore.

Corporate and Regulatory Updates

Cohance Lifesciences

The US Food and Drug Administration issued an Establishment Inspection Report for the company’s Hyderabad manufacturing facility. The inspection was classified as Voluntary Action Indicated, and the regulatory review now stands concluded.

Aarti Drugs

The USFDA inspected the Baddi formulations facility of subsidiary Pinnacle Life Science between November 2 and November 6. The inspection concluded with three observations in Form 483. The company said none of the observations related to data integrity.

Annu Projects

Annu Projects signed a memorandum of understanding with GEIE Solar Products India to procure and supply materials for 8,000 grid-connected rooftop solar systems in Dausa, Rajasthan. The project falls under the PM-Surya Ghar scheme.

Bulk and Block Deals

Lenskart Solutions

SoftBank affiliate SVF II Lightbulb (Cayman) sold 2.72 crore shares, or a 1.56% stake, for Rs 1,896.2 crore. The shares were acquired by 13 domestic and international institutional investors at Rs 697.15 each.

Alivus Life Sciences

Promoter Nirma sold 28.46 lakh shares, representing a 2.31% stake, for Rs 389.94 crore at Rs 1,370 per share. The shares were purchased by investors including Bandhan Mutual Fund, Param Capital, Norges Bank and Helios Mutual Fund. Nirma separately sold another 8.33 lakh shares for Rs 118.57 crore.

Billionbrains Garage Ventures

Peak XV Partners Investments VI-1 sold 6.02 crore shares, representing a 0.95% stake, for Rs 1,295.78 crore. YC Holdings II offloaded 5.5 crore shares, or 0.87%, for Rs 1,160.99 crore. Goldman Sachs Bank Europe SE acquired 3.55 crore shares for Rs 763.58 crore.

V2 Retail

Promoters Ricon Commodities and Ram Chandra Agarwal jointly sold 1.61 crore shares, equivalent to 4.42% of the company’s equity, for Rs 258 crore. Six investors acquired the shares at Rs 160 apiece.

CarTrade Tech

Smallcap World Fund purchased an additional 14.29 lakh shares, or a 2.94% stake, for Rs 369.24 crore. Norges Bank acquired a further 0.6% stake. Macritchie Investments, an indirect Temasek subsidiary, sold 18.2 lakh shares, representing 3.74% of the company. All transactions took place at Rs 2,583 per share.

Windlas Biotech

Stellar Wealth Partners India Fund I acquired 1.5 lakh shares, representing 0.72% of the company’s equity, for Rs 15.35 crore at an average price of Rs 1,020.42 per share.

JSW Cement

Synergy Metals Investments Holding sold 1.9 crore shares, or a 1.4% stake, for Rs 230.13 crore at Rs 120.50 each. Nomura Funds Ireland India Equity Fund purchased 1.2 crore shares, representing 0.88%, at the same price.

Stock in F&O Ban

Kaynes Technology India remains under the futures and options trading ban.